OmniComm Signs Agreement with CROMSOURCE


OmniComm announced the signing of a five-year agreement with CROMSOURCE. OmniComm’s TrialMaster EDC suite will be used for the collection of clinical data in trials spanning all clinical phases and therapeutic areas.

Read the full release here

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.